Found 603 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is B  [Clear All Filters]
2023
Dorkenwald S, Matsliah A, Sterling AR, Schlegel P, Yu S-C, McKellar CE, Lin A, Costa M, Eichler K, Yin Y et al..  2023.  Neuronal wiring diagram of an adult brain.. bioRxiv.
Lai Y, Zhao C, Tian Z, Wang C, Fan J, Hu X, Tu J, Li T, Leitz J, Pfuetzner RA et al..  2023.  Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering.. Proc Natl Acad Sci U S A. 120(44):e2310174120.
Lai Y, Zhao C, Tian Z, Wang C, Fan J, Hu X, Tu J, Li T, Leitz J, Pfuetzner RA et al..  2023.  Neutral lysophosphatidylcholine mediates α-synuclein-induced synaptic vesicle clustering.. Proc Natl Acad Sci U S A. 120(44):e2310174120.
Naguib S, Backstrom JR, Artis E, Ghose P, Stahl A, Hardin R, Haider AA, Ang J, Calkins DJ, Rex TS.  2023.  NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells.. Acta Neuropathol Commun. 11(1):171.
Dhawka L, Palfini V, Hambright E, Blanco I, Poon C, Kahl A, Resch U, Bhawal R, Benakis C, Balachandran V et al..  2023.  Post-ischemic ubiquitination at the postsynaptic density reversibly influences the activity of ischemia-relevant kinases.. bioRxiv.
Dhawka L, Palfini V, Hambright E, Blanco I, Poon C, Kahl A, Resch U, Bhawal R, Benakis C, Balachandran V et al..  2023.  Post-ischemic ubiquitination at the postsynaptic density reversibly influences the activity of ischemia-relevant kinases.. bioRxiv.
Dhawka L, Palfini V, Hambright E, Blanco I, Poon C, Kahl A, Resch U, Bhawal R, Benakis C, Balachandran V et al..  2023.  Post-ischemic ubiquitination at the postsynaptic density reversibly influences the activity of ischemia-relevant kinases.. bioRxiv.
Dhawka L, Palfini V, Hambright E, Blanco I, Poon C, Kahl A, Resch U, Bhawal R, Benakis C, Balachandran V et al..  2023.  Post-ischemic ubiquitination at the postsynaptic density reversibly influences the activity of ischemia-relevant kinases.. bioRxiv.
Gelderblom M, Koch S, Strecker J-K, Jørgensen C, Garcia-Bonilla L, Ludewig P, Schädlich ISophie, Piepke M, Degenhardt K, Bernreuther C et al..  2023.  A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke.. Brain Commun. 5(2):fcad090.
Larivière D, Abueg L, Brajuka N, Gallardo-Alba C, Grüning B, Ko BJune, Ostrovsky A, Palmada-Flores M, Pickett BD, Rabbani K et al..  2023.  Scalable, accessible, and reproducible reference genome assembly and evaluation in Galaxy.. bioRxiv.
Larivière D, Abueg L, Brajuka N, Gallardo-Alba C, Grüning B, Ko BJune, Ostrovsky A, Palmada-Flores M, Pickett BD, Rabbani K et al..  2023.  Scalable, accessible, and reproducible reference genome assembly and evaluation in Galaxy.. bioRxiv.
Joglekar A, Hu W, Zhang B, Narykov O, Diekhans M, Balacco J, Ndhlovu LC, Milner TA, Fedrigo O, Jarvis ED et al..  2023.  Single-cell long-read mRNA isoform regulation is pervasive across mammalian brain regions, cell types, and development.. bioRxiv.
Chiu Y-T, Deutch AY, Wang W, Schmitz GP, Huang KLu, D Kocak D, Llorach P, Bowyer K, Liu B, Sciaky N et al..  2023.  A suite of engineered mice for interrogating psychedelic drug actions.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Pardo-Palacios FJ, Wang D, Reese F, Diekhans M, Carbonell-Sala S, Williams B, Loveland JE, De María M, Adams MS, Balderrama-Gutierrez G et al..  2023.  Systematic assessment of long-read RNA-seq methods for transcript identification and quantification.. bioRxiv.
Bennett NK, Lee M, Orr AL, Nakamura K.  2023.  Systems-level analyses dissociate genetic regulators of reactive oxygen species and energy production.. bioRxiv.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.
Schiff ND, Giacino JT, Butson CR, Choi EYoung, Baker JL, O'Sullivan KP, Janson AP, Bergin M, Bronte-Stewart HM, Chua J et al..  2023.  Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study.. Nat Med.